Cannabis Use Disorder Tied to Incident Cardiovascular Disease Events
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
THURSDAY, Oct. 12, 2023 -- Adults with cannabis use disorder (CUD) have a higher risk for incident adverse cardiovascular disease (CVD) events when compared with matched adults without CUD, according to a study published online Sept. 27 in Addiction.
Anees Bahji, M.D., from the University of Calgary, and colleagues examined the association between CUD and adverse CVD outcomes. The analysis included linked administrative health databases (2012 through 2019) from 29,764 matched pairs of individuals with and without CUD.
The researchers found that approximately 2.4 percent in the CUD group and 1.5 percent in the non-CUD group experienced an incident adverse CVD event (risk ratio, 1.57). There was a significant association observed between CUD and reduced time to an incident CVD event. There was greater risk seen for incident CVD among individuals without mental health comorbidity, those who had not used health care services in the previous six months, those who were not on prescription medications, and individuals who did not have comorbid conditions.
"This evidence suggests that cannabis use may place a healthier population at increased risk of major cardiovascular events," the authors write. "As a result, our study points to the importance of educating our patients about the potential risks associated with cannabis use and CUD."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.